Industrial technology company Emerson has acquired AI software developer Glue Inc. in a move to strengthen its software-defined test and measurement portfolio. The acquisition brings Glue Studio, an AI-powered validation and test planning platform, into Emerson’s NI (National Instruments) ecosystem, extending the capabilities of its domain-specific Nigel™ AI assistant. The deal reflects a broader shift…
ATTACK SHARK is expanding its portfolio of high-performance gaming peripherals with the upcoming launch of the F1 AIR, an ultra-lightweight wireless gaming mouse aimed at competitive esports players. Scheduled to become available for order on August 17, 2026, the flagship device combines a 39g chassis, PixArt PAW3955MAX optical sensor, Nordic nRF54L15 wireless platform, and 8K…
As enterprises move from AI assistants toward autonomous AI agents capable of executing tasks, accessing data, and interacting with business systems, security teams face a new challenge: protecting dynamic AI behavior rather than individual applications. NeuralTrust has launched an AI agent runtime security platform designed to protect multiple AI agents through a single security gateway,…
Sales performance platform Ambition has launched Agent Skills, a new AI workflow library designed to automate core revenue management processes including coaching preparation, pipeline reviews, forecasting analysis, and performance evaluations. The company says the new capability aims to help sales organizations scale consistent coaching practices while giving executives, managers, and sales representatives faster access to…
As enterprises increasingly rely on artificial intelligence for research, analysis, and strategic decisions, accuracy and trustworthiness have become major challenges. CollectivIQ, an AI consensus platform for business intelligence, has released benchmark results showing its multi-model reasoning architecture can outperform individual large language models (LLMs) by combining responses from multiple AI systems, including ChatGPT, Gemini, Claude,…
Artificial intelligence is accelerating the pace of molecular discovery, enabling researchers to generate thousands of potential drug candidates in the time traditional methods required to design only a handful. However, transforming AI-generated designs into viable therapies still depends on experimental validation. GenScript Biotech Corporation and Tamarind Bio are addressing this challenge through a strategic partnership…
Artificial intelligence is increasingly being used to address one of drug development’s biggest challenges: predicting whether promising therapies will succeed in humans. Olio Labs has announced research showing that its AI-powered preclinical platform can forecast potential clinical outcomes, including gastrointestinal side effects, cardiac toxicity, neuropsychiatric effects, and long-term weight changes, using advanced behavioral analysis of…
AI-native imaging company Cephia has appointed semiconductor and computer vision executive Mike McAuliffe as President and Chief Executive Officer, signaling a new phase of commercialization for its next-generation image sensor technology. The leadership move comes as demand grows for compact AI perception systems powering physical AI applications across robotics, automotive, drones, healthcare, satellites, and industrial…
Artificial intelligence and autonomous technologies are moving from experimental concepts into real-world systems that could reshape competitive markets, according to a new analysis from Egan-Jones Ratings Company. The report examines how advances in AI, automation, and autonomous decision-making are challenging traditional business models while creating new considerations for institutional investors, credit analysts, and enterprise risk…
